Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
Oncology|November 27, 2008
Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancerDaisuke Takahari, Yasuhide Yamada, Natuko T Okita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 10, 2009
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestineMakiko Ono, Kuniaki Shirao, Atsuo Takashima, et al.
Surgical Case Reports|May 17, 2022
Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case reportTsunehiko Shigemori, Ichiro Imoto, Yasuhiro Inoue, et al.
Anticancer Research|February 5, 2020
Risk Factors of Severe Benign Cicatricial Stricture After Definitive Chemoradiation for Localized T3 Esophageal CarcinomaNatsuko Satomi-Tsushita, Yoshitaka Honma, Kengo Nagashima, et al.
Journal of Oncology Practice|September 3, 2011
Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trialChiharu Tanai, Takako Eguchi Nakajima, Kengo Nagashima, et al.
International Journal of Clinical Oncology|September 27, 2012
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patientsKohei Ogawa, Takao Ueno, Ken Kato, et al.
Oncotarget|December 31, 2015
Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancerNaoki Takahashi, Koh Furuta, Hirokazu Taniguchi, et al.
In Vivo (Athens, Greece)|July 8, 2019
Chemoradiotherapy for Local Recurrence of Rectal Cancer: A Single Center Study of 18 PatientsJunko Watanabe, Hirokazu Shoji, Tetsuya Hamaguchi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2020
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapyYusuke Nagata, Ken Kato, Takahiro Miyamoto, et al.
Japanese Journal of Clinical Oncology|May 11, 2006
Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancerYasuhide Yamada, Atsushi Ohtsu, Narikazu Boku, et al.
Pageof 22